Cite

HARVARD Citation

    Depuydt, P. et al. (2018). Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients. Journal of the National Cancer Institute. pp. 1084-1093. [Online]. 
  
Back to record